BioSpace News Archive

Business

Nordic Nanovector Appoints Tone Kvåle as Interim Chief Executive Officer

Nordic Nanovector ASA (OSE: NANO) announces that it has appointed Tone Kvåle to the position of Interim Chief Executive Officer (CEO) in addition to her current role as Chief Financial Officer

April 20, 2018
·
1 min read
BioMidwest

Prime Therapeutics Finds Costs Double When Switching to New Extended Half-Life Hemophilia Factor Products

Real-world data analysis shows extended half-life coagulation factor products bring high cost

April 20, 2018
·
4 min read
FDA

FDA Accepts Veloxis’s Supplemental New Drug Application for the De Novo Indication for ENVARSUS XR®

Veloxis Pharmaceuticals A/S announced today that the U.S. Food & Drug Administration (FDA) has accepted for standard review the Company’s supplemental New Drug Application (sNDA) which seeks a new indication for ENVARSUS XR (tacrolimus extended-release tablets) for the prophylaxis of organ rejection in kidney transplant patients in combination with other immunosuppressants

April 20, 2018
·
3 min read